Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Chris Lange | Feb 10, 2016 at 8:40 AM EST

Major Biotech Short Interest Continues to Be Mixed

The January 29 short interest data have been compared with the previous report, and short interest was mixed in most…

Chris Lange | Feb 6, 2016 at 10:50 AM EST

How Analysts Value Gilead Now After Earnings

After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction…

Chris Lange | Feb 2, 2016 at 4:31 PM EST

Gilead Rises on Solid HCV Sales and Earnings Beat

Gilead Sciences reported better-than-expected fourth-quarter financial results after the markets closed on Tuesday.

Paul Ausick | Feb 2, 2016 at 4:04 PM EST

Tesla Hits 52-Week Low

February 2, 2016: Here are five stocks trading with heavy volume among 209 equities making new 52-week lows today. Tesla Motors…

Chris Lange | Feb 2, 2016 at 12:55 PM EST

What Expect From Gilead Earnings

Gilead Sciences is set to release its fourth-quarter earnings report after the markets close on Tuesday.

Paul Ausick | Feb 1, 2016 at 4:04 PM EST

The 52-Week Low Club for Monday

February 1, 2016: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows today. Gilead…

Lee Jackson | Feb 1, 2016 at 9:50 AM EST

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the…

Paul Ausick | Jan 29, 2016 at 4:04 PM EST

The 52-Week Low Club for Friday

January 29, 2016: Here are four stocks trading with heavy volume among 119 equities making new 52-week lows today. Gilead…

Chris Lange | Jan 28, 2016 at 8:35 AM EST

Short Sellers Increase Bets in Major Biotechs

Short interest increased in most of these selected biotech stocks for the most recent settlement date.

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Jan 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.

Chris Lange | Jan 15, 2016 at 11:35 AM EST

The Unusual Merrill Lynch Upgrade of Gilead Sciences

Merrill Lynch sees some stabilization in the hepatitis C market in 2016 that might allow Gilead Sciences to stay above…

Jon C. Ogg | Jan 15, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.

Chris Lange | Jan 13, 2016 at 8:35 AM EST

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech…

Trey Thoelcke | Jan 8, 2016 at 7:20 AM EST

4 Pharmaceutical Stocks With Big Catalysts Pending in 2016

This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny.…

1 … 27 28 29 30 31 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotech Short Interest Continues to Be Mixed

How Analysts Value Gilead Now After Earnings

Gilead Rises on Solid HCV Sales and Earnings Beat

Tesla Hits 52-Week Low

What Expect From Gilead Earnings

The 52-Week Low Club for Monday

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

The 52-Week Low Club for Friday

Short Sellers Increase Bets in Major Biotechs

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

The Unusual Merrill Lynch Upgrade of Gilead Sciences

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Short Interest Remains Mixed for Major Biotechs

4 Pharmaceutical Stocks With Big Catalysts Pending in 2016

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Gilead Sciences : GILD

All Gilead Sciences Articles

Major Biotech Short Interest Continues to Be Mixed

How Analysts Value Gilead Now After Earnings

Gilead Rises on Solid HCV Sales and Earnings Beat

Tesla Hits 52-Week Low

What Expect From Gilead Earnings

The 52-Week Low Club for Monday

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

The 52-Week Low Club for Friday

Short Sellers Increase Bets in Major Biotechs

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

The Unusual Merrill Lynch Upgrade of Gilead Sciences

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Short Interest Remains Mixed for Major Biotechs

4 Pharmaceutical Stocks With Big Catalysts Pending in 2016

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%